Dr. Filip Delport is currently CTO of Fox Diagnostics, a spin-off of the KULeuven that aims to revolutionize the life sciences industry and research market using its real-time, label-free analysis technology. Dr. Filip Delport graduated in Bioscience Engineering at the KU Leuven in 2006 and obtained a PhD in bionanotechnology in the group of Prof. Lammertyn in 2011 with his work on “Characterisation of DNA functionalized silica nanoparticles for bio-assay development”. During his PhD he also successfully concluded a post graduate in Corporate Finance. Afterwards, he continued his career as senior scientist and consultant, managing several biosensing related projects for the pharma and food sector. In that period he was, together with some colleagues, awarded the first Prize in the Battle of talents business contest, where he first challenged the idea of bringing fiber optic biosensing for diagnostics to a broader public. In 2014 he received an IWT (VLAIO) Innovation Mandate which allowed him to conceptualize the spin off FOx Diagnostics and to expand his expertise in networking and high tech entrepreneurship. In 2016 FOX Diagnostics was effectively founded together with Prof. Lammertyn to bring the fiber optic SPR technology to the market. Recently a second capital round was successfully closed to further expand the company (www.foxdiagnostics.com).